UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurofilament light chain as a biomarker in neurological disorders

Journal of neurology, neurosurgery and psychiatry, 2019-08, Vol.90 (8), p.870-881

2019

Volltextzugriff (PDF)

Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures

Multiple sclerosis, 2022-10, Vol.28 (12), p.1831-1833

2022

Volltextzugriff (PDF)

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis

International journal of molecular sciences, 2021-05, Vol.22 (9), p.4958

2021

Volltextzugriff (PDF)

Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain

Frontiers in neuroscience, 2021-05, Vol.15, p.672954-672954

2021

Volltextzugriff (PDF)

Synaptic Dysfunction in Multiple Sclerosis: A Red Thread from Inflammation to Network Disconnection

International journal of molecular sciences, 2021-09, Vol.22 (18), p.9753

2021

Volltextzugriff (PDF)

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

Alzheimer's research & therapy, 2018-01, Vol.10 (1), p.8-8, Article 8

2018

Volltextzugriff (PDF)

High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease

Amino acids, 2021-03, Vol.53 (3), p.435-449

2021

Volltextzugriff (PDF)

Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP

Neurobiology of disease, 2023-12, Vol.189, p.106356-106356, Article 106356

2023

Volltextzugriff (PDF)

Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms

Journal of neuroinflammation, 2021-11, Vol.18 (1), p.259-259, Article 259

2021

Volltextzugriff (PDF)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis

The Lancet regional health. Europe, 2022-11, Vol.22, p.100512-100512, Article 100512

2022

Volltextzugriff (PDF)

The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI

Journal of neurology, 2022-06, Vol.269 (6), p.3129-3135

2022

Volltextzugriff (PDF)

Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics

Cells (Basel, Switzerland), 2021-07, Vol.10 (8), p.1930

2021

Volltextzugriff (PDF)

Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis

Frontiers in immunology, 2020-02, Vol.11, p.157-157

2020

Volltextzugriff (PDF)

The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis

International journal of molecular sciences, 2024-01, Vol.25 (1), p.139

2024

Volltextzugriff (PDF)

Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease

Biochimica et biophysica acta. Proteins and proteomics, 2020-12, Vol.1868 (12), p.140537-140537, Article 140537

2020

Volltextzugriff (PDF)

The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers

Biomolecules (Basel, Switzerland), 2020-02, Vol.10 (2), p.335

2020

Volltextzugriff (PDF)

Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis

Neurobiology of disease, 2018-05, Vol.113, p.97-108

2018

Volltextzugriff (PDF)

Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4440

2021

Volltextzugriff (PDF)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders

Frontiers in neuroscience, 2021-03, Vol.15, p.647783-647783

2021

Volltextzugriff (PDF)

Biomarker-Based Prediction of Parkinson Disease: Time for a Shift in Neurologists' Attitude Toward Neurodegenerative Diseases

Neurology, 2024-08, Vol.103 (3)

2024

Volltextzugriff (PDF)

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers

Neural regeneration research, 2021-01, Vol.16 (1), p.36-42

2021

Volltextzugriff (PDF)

NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use

Neurology, 2022-05, Vol.98 (22), p.911-912

2022

Volltextzugriff (PDF)

Author Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use

Neurology, 2022-11, Vol.99 (19), p.869-869

2022

Volltextzugriff (PDF)

Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum

Alzheimer's research & therapy, 2023-07, Vol.15 (1), p.124-124, Article 124

2023

Volltextzugriff (PDF)

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study

Frontiers in immunology, 2023, Vol.14, p.1327947-1327947

2023

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(100)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Neurofilament light chain as a biomarker in neurological disorders

Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis

Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain

Synaptic Dysfunction in Multiple Sclerosis: A Red Thread from Inflammation to Network Disconnection

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease

Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP

Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis

The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI

Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics

Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis

The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis

Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease

The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers

Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis

Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders

Biomarker-Based Prediction of Parkinson Disease: Time for a Shift in Neurologists' Attitude Toward Neurodegenerative Diseases

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers

NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use

Author Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use

Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study

Suchergebnisse filtern